Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2065 of 6351
-
New hope for teen moms: drug targets postpartum depression
Symptom relief CompletedThis is a multi-center study evaluating the safety, tolerability, and pharmacokinetics of brexanolone in the treatment of adolescent female participants with postpartum depression (PPD).
Phase 3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:22 UTC
-
Fast MRI finds cancers mammograms miss in breast cancer survivors
Diagnosis Completed500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. status post primary breast cancer treated with breast conservation therapy 3 years prior to recruitment 2. negativ…
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Gut health may hold key to preventing mania relapse
Disease control CompletedThis will be a 24-week, randomized, double-blind, placebo-controlled trial of adjunctive probiotic therapy in 66 persons hospitalized with a manic or mixed episode. The active study compound will consist of capsules containing approximately 10\^9 colony forming units of the probi…
Phase 3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Shocking the bladder into behaving: new implant shows promise
Symptom relief CompletedThis trial is a prospective, multicenter, single-arm study of the safety and effectiveness of eCoinTM tibial nerve stimulation in subjects having overactive bladder (OAB) with urgency urinary incontinence (UUI). The study will evaluate changes from baseline in OAB symptoms as mea…
Sponsor: Valencia Technologies Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Brain drain: can shunt surgery reverse cognitive decline and frailty?
Knowledge-focused CompletedThe goal of this observational study is to describe changes in cognitive profile and frailty from pre shunt to one year after the shunt surgery and to identify clinical predictors of an improvement in terms of cognition and frailty during the same period. The main objective is to…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Should we operate sooner on enlarged aortas? major trial aims to settle debate
Disease control Recruiting nowThe ascending aorta conducts blood from the heart to the rest of the body. The ascending aorta can become enlarged, and the risk of tearing and rupturing becomes higher with larger aorta. When the ascending aorta tears or ruptures, the risk dying is high even if surgery is done a…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Which blood thinner works best after heart device implant? new trial aims to find out
Disease control OngoingThe objective of the study is to compare short-term (8 weeks) anticoagulation therapy (DOAC) vs. antiplatelet therapy for the prevention of device thrombosis following transcatheter LAAC.
Phase 4 • Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Old asthma drug shows promise for rare genetic disorder
Disease control OngoingPseudohypoparathyroidism is a genetic disorder with limited treatment options. Patients have early-onset obesity, short stature and increased risk of type 2 diabetes. This phase 2 clinical trial will test the efficacy of theophylline, a phosphodiesterase inhibitor, in pseudohypop…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Engineered immune cells take aim at HPV-Positive cancers
Disease control CompletedHuman papillomavirus infections 16 (HPV16) is known to be a high-risk factor to induce cervical cancers. To date, HPV16-related cervical cancer is still a major concern in developing countries where vaccination is not prevalent. Concurrent therapies for cervical cancers have limi…
Phase 1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Smaller incision, faster recovery? new trial tests heart bypass techniques
Symptom relief OngoingMICS CABG (Minimally invasive coronary surgery), where coronary artery bypass grafting (CABG) is completed through a small incision over the left chest, has evolved to become a safe and less invasive alternative to conventional sternotomy CABG. Several observational studies have …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Gene therapy for rare liver disease: Long-Term safety check
Disease control OngoingDetermine the long-term safety of DTX301 following a single intravenous (IV) dose in adults with late-onset ornithine transcarbamylase (OTC) deficiency.
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Three-Dose radiation breakthrough for breast cancer patients
Disease control CompletedThe investigators proposed approach allows them to deliver a low total dose of radiation to patients with low-risk, early-stage breast cancer which would further minimize the impact of adjuvant therapy. This work has the potential to revolutionize partial breast irradiation by al…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Less fluid, better recovery? new trial tests approach in injured kids
Disease control Recruiting nowThis study is designed to help decide how much intravenous (IV) fluid should be given to pediatric trauma patients. No standard currently exists for managing fluids in critically ill pediatric trauma patients, and many fluid strategies are now in practice. For decades, trauma pat…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental immune therapy for childhood brain cancer shows early safety signals
Disease control Stopped earlyIt is believed that the body's immune system protects the body by attacking and killing tumor cells. T-lymphocytes (T-cells) are part of the immune system and can attack when they recognize special proteins on the surface of tumors. In most patients with advanced cancer, T-cells …
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for PNH patients: Long-Term drug safety confirmed
Disease control CompletedThis is an Open-label, Non-Randomized, Multi-Center Extension Study. Eligible subjects will have previously completed a pegcetacoplan study.
Phase 3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Simple home help and exercise may keep seniors independent after hospitalization
Symptom relief CompletedThis study evaluates whether the utilization of integrated health services such as help with medications, muscle strengthening, balance training, pain management and home modification interventions can help improve older adults' ability to sleep, balance, walk, and take care of t…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Diabetes drug and healthy habits tested to stop irregular heartbeat
Prevention OngoingProspective randomized open-label blinded endpoint (PROBE) 2x2 factorial study of metformin extended release up to 750 mg BID and lifestyle and risk factor modification (LRFM) in CIED patients with at least 1 ≥5 minute episode of AF over the prior 3 months. Randomization will be …
Phase 4 • Sponsor: Mina Chung, MD • Aim: Prevention
Last updated Jun 26, 2026 16:26 UTC
-
Experimental antibody drug tested for Tough-to-Treat leukemia
Disease control Stopped earlyThis phase I/II trial studies the side effects and best dose of ADCT-602 in treating patients with B-cell lymphoblastic leukemia that has come back or does not respond to treatment. Monoclonal antibodies, such as ADCT-602, may interfere with the ability of tumor cells to grow and…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug combo shows promise for tough brain cancer
Disease control CompletedThe purpose of this study is to test the safety of combined use of the study drugs, copanlisib and ibrutinib, in people with PCNSL.
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug cocktail shows promise for Hormone-Sensitive uterine cancer
Disease control CompletedThe purpose of this study is to determine the effectiveness of the combination of abemaciclib and fulvestrant in treating this type of cancer and to determine the types and severity of side effects caused by treatment with abemaciclib and fulvestrant.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC